Form 4 for MLYS Mineralys Therapeutics, Inc.
Accepted 2026-08-12 19:33:20 ET · period of report 2026-08-10 · accession 0001933414-26-000120 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-12 19:33 | 2026-08-10 | MLYS | Ferguson James J. III | Chief Medical Off | A - Grant | $0.00 | +102.4K | 102.4K | New | $0 |
| D | 2026-08-12 19:33 | 2026-08-10 | MLYS | Ferguson James J. III | Chief Medical Off | A - Grant | $0.00 | +135.0K | 135.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-10 | A | A | 102,400 | $0.00 | 102,400 | D | — | — | (F1) Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of the date of grant. |
| 2 | Derivative | Stock Option | 2026-08-10 | A | A | 135,000 | $0.00 | 135,000 | D | $27.38 · — to 2036-08-10 | 135,000 Common Stock | (F2) The stock option vests as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter. |